Loading insider details...
Latest Form 4 (Aug 20, 2026): Exercise/Conversion of 573 CRL shares, $94.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Exercise/Conversion | 573 | $94.1K |
| Jun 10, 2026 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| May 14, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Gift | 3,964 | n/a |
| May 11, 2026 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 1,438 | $255.4K |
| Sep 24, 2025 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| May 23, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 946 | $127.7K |
| May 15, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 559 | $127.7K |
| May 17, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 664 | n/a |
| May 13, 2022 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 575 | n/a |
| May 10, 2021 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/Award | 355 | n/a |